All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 163 of 206 pages ‹ First < 161 162 163 164 165 > Last ›
HSL165
Willman D.
Case Studies: Drug After Drug,Warnings Ignored Propulsid: A Heartburn Drug, Now Linked to Children's Deaths Once evidence of harm emerged, FDA took years to withdraw approval.
The Los Angeles Times 2000 Dec 20
HSL166
Willman D.
RAXAR: Warning on Label Omits Deaths Heart problems were mentioned in fine print, but not key dosage data.
The Los Angeles Times 2000 Dec 20
HSL168
Willman D.
REDUX: Unheeded warnings on Lethal Diet Pill Heart damage causes billions of dollars in potential legal liability.
The Los Angeles Times 2000 Dec 20
HSL169
Willman D.
DURACT: Painkiller Posed Risk of Damage to Liver Drugmaker's lobbying won fine print instead of prominent warning.
The Los Angeles Times 2000 Dec 20
HSL170
Willman D.
POSICOR: 143 Sudden Deaths Did Not Stop Approval With study results kept secret, nation got another blood-pressure drug.
The Los Angeles Times 2000 Dec 20
HSL171
Willman D.
LOTRONEX: Officer Foresaw Deadly Effects
The Los Angeles Times 2000 Dec 20
http://www.whale.to/drugs/lotronex.html
HSL173
Willman D.
REZULIN: Fast-Track Approval and a Slow Withdrawal Diabetes drug stayed on the market a year after being listed among the most risky.
The Los Angeles Times 2000 Dec 20
HSL175
Willman D.
RELENZA: Official Asks If One Day Less of Flu Is Worth It Still on the market, the drug has been linked to 22 deaths so far.
The Los Angeles Times 2000 Dec 20
HSL20119
Fountain B
Advertise and be damned
New Zealand Doctor 2000 Dec 202
HSL7894
Walley T, Earl-Slater A, Haycox A, Bagust A.
An integrated national pharmaceutical policy for the United Kingdom?
BMJ 2000 Dec 16;321:(7275):1523-6
http://www.bmj.com/cgi/content/full/321/7275/1523
HSL16741
Barbehenn E, Lurie P, Wolfe SM.
Alosetron for irritable bowel syndrome.
Lancet 2000 Dec 9;356:(9246):2009-10
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(05)72978-0
HSL20235
The Third-Person Effect
The Wager 2000 Dec 6
http://www.basisonline.org/2000/12/the-wager-vol-5.html
HSL18020
Moynihan R, Sweet M.
Medicine, the media and monetary interests: the need for transparency and professionalism.
Med J Aust 2000 Dec 4-18;173:(11-12):631-4
http://www.mja.com.au/public/issues/173_11_041200/moynihan/moynihan.html
HSL7909
Thompson CA.
Federal drug discount program proves tricky for hospitals to navigate
American Journal of Health System Pharmacy 2000 Dec 1;57:2130, 2134, 2139-2140
HSL213
Morgan S, Barer M, Evans R.
Health economists meet the fourth tempter: drug dependency and scientific discourse.
Health Econ 2000 Dec;9:(8):659-67
http://www3.interscience.wiley.com/cgi-bin/abstract/76505087/ABSTRACT
HSL223
Knox KS, Adams JR, Djulbegovic B, Stinson TJ, Tomor C, Bennet CL.
Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology.
Ann Oncol 2000 Dec;11:(12):1591-5
HSL232
Bell RA, Wilkes MS, Kravitz RL.
The educational value of consumer-targeted prescription drug print advertising.
J Fam Pract 2000 Dec;49:(12):1092-8
HSL6972
[No authors listed]
Trial results must be accessible: Clinical research data, a public asset.
Prescrire Int. 2000 Dec;9:(50):183
HSL7903
Richardson K, Basskin L.
Cost benefit analysis of methods used to access manufacturers' pharmaceutical assistance programs
ASHP Midyear Clinical Meeting 2000 Dec;35:
HSL7918
Hailemeskel B, Gavgani MZ.
Assessment of accuracy and completeness of the prescription drug information on the Internet
ASHP Midyear Clinical Meeting 2000 Dec;35:
HSL7919
Murray SG, Albano DL, Buttaro ML, Goldkamp AH.
Evaluation of health care professional satisfaction with a pharmaceutical industry's standard response letters and assessment of their impact on prescribing behavior
ASHP Midyear Clinical Meeting 2000 Dec;35:
HSL7920
Schultz PT, Hogan TT, Clark KE.
Assessment of the impact of direct to consumer advertising of prescription drugs on consumers and prescribers
ASHP Midyear Clinical Meeting 2000 Dec;35:
HSL20291
Messmer JJ, Parnes B, Westfall JM
Influence of pharmaceutical companies
The Journal of Family Practice 2000 Dec;49:(12):1154
http://www.jfponline.com/Pages.asp?AID=2666
HSL206
McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP, Brody BA.
A national survey of policies on disclosure of conflicts of interest in biomedical research.
N Engl J Med 2000 Nov 30;343:(22):1621-6
http://content.nejm.org/cgi/content/abstract/343/22/1621
HSL222
Lo B, Wolf LE, Berkeley A.
Conflict-of-interest policies for investigators in clinical trials.
N Engl J Med 2000 Nov 30;343:(22):1616-20
http://content.nejm.org/cgi/content/abstract/343/22/1616
HSL2634
Martin JB, Kasper DL.
In whose best interest? Breaching the academic-industrial wall
New England Journal of Medicine 2000 November 30;343:(22):1646-1649
http://content.nejm.org/cgi/content/extract/343/22/1646
HSL2577
Weber W.
Merck Sharp & Dohme prosecuted for pampering Dutch doctors
Lancet 2000 Nov 25;356:1832
HSL19753
Gilbert D, Walley T, New B
Lifestyle medicines
BMJ 2000 Nov 25;321:1341-1344
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1119073/
HSL3678
Findlay S.
Prescription Drugs and Mass Media Advertising.
Washington, DC: National Institute of Health Care Management. 2000 Nov
http://web.archive.org/web/20080304043214/http://www.nihcm.org/publications/prescription_drugs
HSL1416
Jureidini JN.
Epidemic of schizophrenia in children or inappropriate prescribing?
Med J Aust 2000 Nov 20;173:(10):555-6
HSL20156
Maling N
Drug advertising costs hard to swallow
Sunday Star Times 2000 Nov 19A6
HSL20144
Hall S
Direct drug advertising opposed
Australian Doctor 2000 Nov 17
HSL19535
Stolberg SG, Gerth J
High-Tech Stealth Being Used to Sway Doctor Prescriptions
The New York Times 2000 Nov 16
http://www.nytimes.com/2000/11/16/us/high-tech-stealth-being-used-to-sway-doctor-prescriptions.html
HSL19536
Petersen M.
Growing Opposition to Free Drug Samples
The New York Times 2000 Nov 15
http://www.nytimes.com/2000/11/15/business/growing-opposition-to-free-drug-samples-ultimate-costs-and-safety-are-cited.html
HSL2632
McCarthy M.
Company sought to block paper's publication
Lancet 2000 Nov 11;356:1659
HSL2583
Summers W, Driscoll J, Orient J.
The pharmaceutical industry - to whom is it accountable? (7th of 10 letters)
New England Journal of Medicine 2000 Nov 9;343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415
HSL2586
Schwarting J.
The pharmaceutical industry - to whom is it accountable? (3rd of 10 letters)
New England Journal of Medicine 2000 Nov 9;343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415
HSL2587
Schwarting JS.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9;343:(19):1416
HSL2594
Rightor N.
The pharmaceutical industry - to whom is it accountable? (6th of 10 letters)
New England Journal of Medicine 2000 Nov 9;343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415
HSL2602
Reif M.
The pharmaceutical industry - to whom is it accountable? (2nd of 10 letters)
New England Journal of Medicine 2000 Nov 9;343:(19):1415-6
http://content.nejm.org/cgi/content/full/343/19/1415
HSL2629
Mehta DJ.
The pharmaceutical industry - to whom is it accountable? (9th of 10 letters)
New England Journal of Medicine 2000 Nov 9;343:(19):1417
HSL6968
Bohrer RA.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9;343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415
HSL6969
Hayes TA.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9;343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415
HSL6970
Holmer AF.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9;343:(19):1415
http://content.nejm.org/cgi/content/full/343/19/1415
HSL6971
Jacobs C.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9;343:(19):1416-7
http://content.nejm.org/cgi/content/full/343/19/1415
HSL20097
Sweet M
Transparency with a mud-like clarity
Australian Doctor 2000 Nov 329
HSL20112
St John P
GPs hail TV ads review
Australian Doctor 2000 Nov 335
HSL2016
Biotech Firm Tries to Suppress Publication of Research: Academic Freedom at Heart of Issue
Journal of the American Medical Association 2000 Nov 1
HSL18019
Kravitz RL
Direct-to-Consumer Advertising of Prescription Drugs: Implications for the Patient-Physician Relationship
JAMA 2000 Nov 1;284:(17):2244
http://jama.ama-assn.org/cgi/content/full/284/17/2244
HSL20366
Capozzi JD, Rhodes R
Ethics in Practice : Advertising and Marketing
The Journal of Bone and Joint Surgery 2000 Nov 1;82:(11):1668-1668
http://jbjs.org/article.aspx?articleid=24482
HSL1855
Potdar RD.
Educating ourselves.
Indian Pediatr 2000 Nov;37:(11):1287-8
http://www.indianpediatrics.net/nov2000/nov-1287-1288.htm
HSL3695
Rowsell LB.
Policy statement. Advertising campaigns of branded and unbranded messages.
: Therapeutic Products Directorate, Health Canada. 2000 Nov
http://www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/policy/issued/adv_campaign_e.html.
HSL7895
Wechsler J.
FDA launches debate on renewing user fees and updating FDA Modernization Act
Formulary 2000 Nov;35:925-926
HSL7897
Pines WL.
Direct-to-consumer advertising.
Ann Pharmacother 2000 Nov;34:(11):1341-4
http://www.theannals.com/cgi/reprint/34/11/1341
HSL20295
Lock CA, Kaner EF.
Use of marketing to disseminate brief alcohol intervention to general practitioners: promoting health care interventions to health promoters.
J Eval Clin Pract 2000 Nov;6:(4):345-57
http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2753.2000.00268.x/abstract;jsessionid=85C526DBB3BACF2AD9AFBDBC6FACC95A.d03t04
HSL16022
Zoutman DE, Ford BD, Bassili AR.
A call for the regulation of prescription data mining
CMAJ 2000 Oct 30;163:(9):1146
http://www.cmaj.ca/cgi/content/full/163/9/1146
HSL7038
More U.S. Children Being Diagnosed With Youthful Tendency Disorder
The Onion 2000 Oct 27
HSL7816
Tieman J.
Just roiling along.
Mod Healthc 2000 Oct 23;30:(44):8-9
HSL16740
Wolfe S, Lurie P
Protecting Patients in Medical Research
The Washington Post 2000 Oct 17
HSL19537
Page L
More Clinics Ban Drug Samples, Citing Cost, Safety Concerns
American Medical News 2000 Oct 16
http://www.ama-assn.org/amednews/2000/10/16/bil11016.htm
HSL6967
Kiln MR, Hirst JMD.
Academia and industry
Lancet 2000 Oct 14;356:1359
HSL18018
Reichert S, Simon T, Halm EA.
Physicians' attitudes about prescribing and knowledge of the costs of common medications.
Arch Intern Med 2000 Oct 9;160:(18):2799-803
http://archinte.ama-assn.org/cgi/content/full/160/18/2799
HSL20104
Mold F
Emotive drug advertising put on report
The New Zealand Herald 2000 Oct 9
http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=154568
HSL20177
Mold F
Emotive drug ads put on report
NZ Herald 2000 Oct 9
HSL226
Freemantle N, Anderson IM, Young P.
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
Br J Psychiatry 2000 Oct;177:292-302
http://bjp.rcpsych.org/cgi/content/full/177/4/292
HSL2099
Norman GR.
The epistemology of clinical reasoning: perspectives from philosophy, psychology, and neuroscience.
Acad Med 2000 Oct;75:(10):
http://www.academicmedicine.org/cgi/content/full/75/10/S127?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Norman+G&titleabstract=epistemology&searchid=1124492605605_451&stored_search=&FIRSTINDEX=0&journalcode=acadmed
HSL2582
Susman E.
No such thing as a free lunch
Scrip Magazine 2000 October;94:(19):
HSL2627
Mintzes B, Lippman A.
Re: Selling, or selling out? [response]
Journal of the Society of Obstetricians and Gynaecologists of Canada 2000 Oct;22:(10):786-787
HSL4817
Bhatt AD.
Clinical trial publications.
Issues Med Ethics 2000 Oct-Dec;8:(4):119-21
HSL5690
Kimanani E, Stypinski D, Curtis G, Stiles M, Heessels P, Logan S, Nelson K, St Germain E, Boswell G.
A contract research organization's response to the new FDA guidances for bioequivalence/bioavailability studies for orally administered drug products.
J Clin Pharmacol 2000 Oct;40:(10):1102-8
HSL6963
Baumgartner A.
Re: Selling, or selling out?
Journal of the Society of Obstetricians and Gynaecologists of Canada 2000 Oct;22:(10):786
HSL6964
Feldman W.
The pharmaceutical industry/L'industrie pharmaceutique
Annales CRMCC 2000 Oct;33:(7):404-405
HSL6965
Kravitz RL.
Direct-to-consumer advertising of prescription drugs.
West J Med 2000 Oct;173:(4):221-2
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=11017964
HSL6966
Davis JJ.
Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs
J Health Commun 2000 Oct;5:(4):349-69
HSL7823
Challenges and opportunities in the Canadian drug industry
HealthCare Distributors 2000 Oct;52:18, 20-21
HSL19538
The Fiscal Policy Institute for USAction
Impossible Choices: Food and Housing or Prescription Drugs?
Fiscal Policy Institute 2000 Oct
www.fiscalpolicy.org/downloads/ImpossibleChoices.pdf
HSL19819
Wagner E, Tumas JA, Field EA, Glazer NB, Schulz G, Grossman L
Letter To The Editor: Good Publication Practice Guidelines For Pharmaceutical Companies
CMAJ 2000 Oct;14:(9):749
HSL20089
Charatan F
US presciption drug sales boosted by advertising
BMJ 2000 Sep 30;321:(7264):783
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118601/
HSL228
de Barros JAC.
One more case of the double standard: discrepancies between drug information provided to Brazilian and American physicians
Pharmacoepidemiology and Drug Safety 2000;9:281-287
http://www3.interscience.wiley.com/cgi-bin/abstract/73501719/ABSTRACT
HSL19541
Pear R
Marketing Tied to Increase in Prescription Drug Sales
The New York Times 2000 Sep 20
http://www.nytimes.com/2000/09/20/us/marketing-tied-to-increase-in-prescription-drug-sales.html?pagewanted=all&src=pm
HSL2584
Sullivan P.
Freebies to MDs targeted as drug industry starts publicizing CME fines
Canadian Medical Association Journal 2000 Sep 19;163:(6):749
HSL6962
Horton R.
The less acceptable face of bias.
Lancet 2000 Sep 16;356:(9234):959-60
http://linkinghub.elsevier.com/retrieve/pii/S0140673600027112
HSL6961
Bruera E, Ripamonti C, Beattie-Palmer L.
Use of trade names of drugs in abstracts from pain congresses.
N Engl J Med 2000 Sep 14;343:(11):818
HSL2015
Borger J.
Dirty rats leave Gore a subliminal message
The Guardian 2000 Sep 13
http://www.guardian.co.uk/world/2000/sep/13/uselections2000.usa
HSL7906
Kirkpatrick MA, Shadis ER.
Pharmacy connect-free drug program for community dwelling elders
Journal of the American Pharmaceutical Association 2000 Sep 10;40:672-674
HSL2014
Medawar C
Costly benefits and the conspiracy of goodwill
Paper given at the annual meeting of the British Association for the Advancement of Science 2000 Sep 9
HSL19856
Kent A
Not another magic bullet
BMJ 2000 Sep 9;321:(7261):644
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118524/
HSL1857
Drug-company influence on medical education in USA
Lancet 2000 Sep 2;356:(9232):781
http://linkinghub.elsevier.com/retrieve/pii/S0140673600026453
HSL2633
McCarthy M.
Conflict of interest taints vaccine approval process, charges US report.
Lancet 2000 Sep 2;356:(9232):838
HSL18017
Farrell L
Ads: O Liberty! what crimes are committed in thy name!
BMJ 2000 Sep 2;321:(7260):578
http://www.bmj.com/cgi/content/citation/321/7260/578
HSL2615
Wenger NS, Lieberman JR.
The orthopaedic surgeon and industry. Ethics and industry incentives.
Clinical Orthopaedics and Related Research 2000 September 01;(378):39-43
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10986972http://
HSL233
Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF.
The value of pharmaceutical representative visits and medication samples in community-based family practices.
J Fam Pract 2000 Sep;49:(9):811-6
HSL2589
Sams WM, Freedberg IM.
The dermatology-industry interface: defining the boundaries.
J Am Acad Dermatol 2000 Sep;43:(3):550-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10954674
HSL3682
Galbally R.
Review of drugs, poisons, and controlled substances legislation. Draft Final Report.
Canberra: Therapeutic Goods Administration, 2000 Sep
HSL6960
Gifts: a transcript of a television report
MaLAM International News 2000 Sep-Oct;18:(9-10):1-4
HSL7847
Thompson L.
User fees for faster drug reviews: are they helping or hurting the public health?
FDA Consumer 2000 Sep-Oct;34:25-29
HSL19780
Sara G, Prior N
Drug Companies and CME: Prohibition, Declaration or Engagement?
Australas Psychiatry 2000 Sep;8:(3):195-198
http://apy.sagepub.com/content/8/3/195.full
HSL3701
Petersen M.
What’s black and white and sells medicine?
NY Times 2000 Aug 2712 [sect 3, p1].
HSL14738
Stock S.
Luxury lures give doctors the drug company habit
The Australian 2000 Aug 26-27
HSL20133
Humphreys L
King out to stop TV ads for products like Viagra
The Daily News 2000 Aug 26
Page 163 of 206 pages ‹ First < 161 162 163 164 165 > Last ›
